Insider Trading April 21, 2026 06:13 PM

Aehr Test Systems VP of Sales and Marketing Disposes $610,270 in Stock

Sale by Vernon Rogers follows recent capital raise and a record production order as analysts update targets amid mixed quarterly results

By Avery Klein AEHR
Aehr Test Systems VP of Sales and Marketing Disposes $610,270 in Stock
AEHR

Vernon Rogers, Executive Vice President of Sales and Marketing at Aehr Test Systems (NASDAQ: AEHR), sold 6,486 shares on April 21, 2026, for $94.0904 each, totaling $610,270. The sale leaves Rogers with a direct holding of 152,716 shares, a figure that includes unvested restricted stock units. The company recently completed a $60 million at-the-market offering, reported a record $41 million production order from a hyperscale customer for package-level burn-in of custom AI processor ASICs, and posted Q3 FY26 results with $10.3 million in revenue and a record $37.2 million in quarterly bookings.

Key Points

  • Executive sale: Vernon Rogers sold 6,486 shares on April 21, 2026, for $610,270 total; he now directly holds 152,716 shares including unvested RSUs.
  • Corporate finance: Aehr Test Systems completed a $60 million at-the-market common stock offering as disclosed in an SEC filing.
  • Operational momentum: The company secured a record $41 million production order from a hyperscale customer for package-level burn-in of custom AI processor ASICs, with deliveries starting in fiscal 2027.

Vernon Rogers, who serves as Executive Vice President of Sales and Marketing at Aehr Test Systems (NASDAQ: AEHR), executed a sale of 6,486 shares of the company's common stock on April 21, 2026. The shares were sold at $94.0904 apiece, generating gross proceeds of $610,270.

Following the transaction, Rogers is reported to directly own 152,716 shares of Aehr Test Systems common stock. That total explicitly includes shares that remain subject to unvested restricted stock units.

Separately, the company disclosed that it has completed a $60 million at-the-market stock offering, according to a filing with the Securities and Exchange Commission. The proceeds were raised via sales of common stock conducted under an effective registration statement.

In operational developments announced by the company, Aehr Test Systems said it secured a record production order valued at $41 million from a hyperscale customer. The order is for package-level burn-in of custom AI processor ASICs and includes high-power package-level test and burn-in systems. Deliveries for this order are scheduled to commence in the company’s fiscal 2027.

On the analyst front, Freedom Broker raised its price target on Aehr Test Systems to $61 while maintaining a Hold rating, citing continued strong demand metrics despite a modest revenue shortfall in Q3 FY26. Lake Street also increased its price target to $56 and maintained a Buy rating, pointing to robust bookings momentum.

Financially, Aehr Test Systems reported Q3 revenue of $10.3 million, a figure described as slightly below consensus estimates. Nonetheless, the company recorded quarterly bookings of $37.2 million, a record, and reported an effective backlog that now exceeds $50 million.

Market-value commentary included an InvestingPro analysis indicating the stock appears overvalued at current levels, with further detail available through Pro Research Reports.


Contextual summary

  • The insider sale by Rogers generated $610,270 on April 21, 2026, and left him with 152,716 shares, including unvested RSUs.
  • The company completed a $60 million at-the-market offering and reported a $41 million production order from a hyperscale customer for package-level burn-in systems, with deliveries beginning in fiscal 2027.
  • Q3 FY26 revenue was $10.3 million, slightly under expectations, while bookings reached a record $37.2 million and effective backlog exceeds $50 million.

Key takeaways

  • Insider activity: A senior sales executive sold a material block of shares, reducing his direct holding to 152,716 shares, including unvested units.
  • Capital markets: Aehr completed a $60 million at-the-market offering, increasing the company's available capital through common stock sales.
  • Demand and orders: The company reported a record $41 million production order for package-level burn-in of custom AI processor ASICs, with deliveries slated to begin in fiscal 2027.

Risks and uncertainties

  • Valuation concern - An InvestingPro analysis indicates the stock appears overvalued at current levels.
  • Revenue execution - Q3 FY26 revenue of $10.3 million came in slightly below consensus estimates, which may reflect short-term execution or timing issues.
  • Share dilution - The completion of a $60 million at-the-market offering involved sales of common stock, which can have dilutive effects for existing shareholders.

Risks

  • InvestingPro indicates the stock appears overvalued at current levels, suggesting valuation risk for investors.
  • Q3 FY26 revenue of $10.3 million was slightly below consensus estimates, introducing short-term execution or revenue risk.
  • The $60 million at-the-market offering involved sales of common stock, which may dilute existing shareholders and affect per-share metrics.

More from Insider Trading

CrowdStrike CEO George Kurtz Sells $2.13M in Stock Under Prearranged Plan Apr 21, 2026 Third Rock Ventures Sells $17.1M Stake in Rapport Therapeutics Apr 21, 2026 Astera Labs CEO Sells $57.85 Million in Stock; Holdings and Analyst Views Highlighted Apr 21, 2026 Aehr Test Systems Director Scott Gates Disposes $5.66 Million in Shares Apr 21, 2026 Arista Networks CTO Kenneth Duda Sells $9.47M in Stock as Shares Trade Near 52-Week High Apr 21, 2026